BioSpace News Archive

The financing was co-led by Advantech Capital and SDIC Venture Capital.

The company will undergo a reorganization that includes the termination of a number of sales representatives.

Zhejiang DTRM Biopharma announced a $60M Series A round that will support clinical trials of its lead cancer candidate, a Bruton’s tyrosine kinase inhibitor.

Piper Jaffray & Co. is acting as the sole manager for the offering.

The trial enrolls adult male patients affected by AMN, the most frequent phenotype of X-linked adrenoleukodystrophy.

Ms. McDonnell will report to Jim Hawkins, CEO, and will be responsible for leading and expanding Natus’ newborn care business.

Advanced Bifurcation Systems is developing a new procedure that could potentially eliminate the need for open-heart surgery in thousands of patients every year.

Jan. 5, 2018 16:24 UTC SolveBio Awarded $1.5 Million from the National Institutes of Health to Expand Genomic Applications in Precision Medicine NEW YORK--( BUSINESS WIRE )-- SolveBio announced today it has been awarded $1,497,112 by the National Institute of General Medical Sciences (NIGMS) for the project titled: “The Variant Explorer: a cloud-based data integration and visualization system for improving clinical interpret

Amarin plans to discuss these results and expectations with investors in connection with the 36th Annual J.P. Morgan Healthcare Conference.

The study investigated the ability of the iTotal CR Knee Replacement System restoring coronal plane mechanical axis alignment in a patient’s leg.